这是一篇来自已证抗体库的有关人类 IL-10 (IL-10) 的综述,是根据120篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IL-10 抗体。
IL-10 同义词: CSIF; GVHDS; IL-10; IL10A; TGIF

赛默飞世尔
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(eBioscience, 12-7108-82)被用于被用于流式细胞仪在人类样本上. J Immunother Cancer (2022) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类; 1:2000; 图 6d
赛默飞世尔IL-10抗体(eBioscience, 14-7108-85)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:2000 (图 6d). Commun Biol (2022) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类; 1:2000; 图 6d
赛默飞世尔IL-10抗体(eBioscience, 13-7109-85)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:2000 (图 6d). Commun Biol (2022) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 s4a
赛默飞世尔IL-10抗体(eBioscience, 12-7108-81)被用于被用于流式细胞仪在人类样本上 (图 s4a). Cell (2019) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类; 图 5c
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于酶联免疫吸附测定在人类样本上 (图 5c). J Immunol (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔IL-10抗体(ebioscience, 16-7108-85)被用于被用于流式细胞仪在人类样本上 (图 4a). Oncotarget (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 3b). J Clin Invest (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 1e
  • 流式细胞仪; 猕猴; 图 6f
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 1e) 和 被用于流式细胞仪在猕猴样本上 (图 6f). PLoS Pathog (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 6c
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 6c). J Immunol (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 s1). Science (2016) ncbi
大鼠 单克隆(JES3-12G8)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4
赛默飞世尔IL-10抗体(Thermo Fisher, JES3-12G8)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4). PLoS ONE (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; African green monkey; 图 5a
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在African green monkey样本上 (图 5a). Infect Immun (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔IL-10抗体(eBioscience, 48-7108)被用于被用于流式细胞仪在人类样本上 (图 6). Nat Commun (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 7). Haematologica (2016) ncbi
小鼠 单克隆(945A2A5)
  • 免疫组化-冰冻切片; 人类; 1:50; 图 2
赛默飞世尔IL-10抗体(生活技术, 945A2A5)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:50 (图 2). F1000Res (2015) ncbi
小鼠 单克隆(945A2A5)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔IL-10抗体(Invitrogen, 945A2A5)被用于被用于免疫组化-石蜡切片在人类样本上. Immunology (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Ebioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; South American squirrel monkey
赛默飞世尔IL-10抗体(Biosource, 945A5A10)被用于被用于酶联免疫吸附测定在South American squirrel monkey样本上. Malar J (2015) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; South American squirrel monkey
赛默飞世尔IL-10抗体(Biosource, 945A5D11)被用于被用于酶联免疫吸附测定在South American squirrel monkey样本上. Malar J (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 免疫细胞化学; 人类
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于免疫细胞化学在人类样本上. Autoimmun Rev (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2014) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Affymetrix eBioscience, JES3?C9D7)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类; 20 ug/ml
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于抑制或激活实验在人类样本上浓度为20 ug/ml. Immunology (2014) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; African green monkey; 10 ug/ml; 图 s4
赛默飞世尔IL-10抗体(eBioscience, JES3-9D7)被用于被用于抑制或激活实验在African green monkey样本上浓度为10 ug/ml (图 s4). Nat Med (2013) ncbi
小鼠 单克隆(945A2A5)
  • 免疫组化-石蜡切片; 人类; 图 2
赛默飞世尔IL-10抗体(Invitrogen, AHC9102)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). Am J Physiol Regul Integr Comp Physiol (2013) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔IL-10抗体(Caltag, clone JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 1). Vaccine (2013) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; 人类; 图 3
赛默飞世尔IL-10抗体(Invitrogen, AHC7109)被用于被用于酶联免疫吸附测定在人类样本上 (图 3). Biosens Bioelectron (2011) ncbi
大鼠 单克隆(JES3-9D7)
  • 免疫细胞化学; 人类; 1 ug/ml; 图 3
赛默飞世尔IL-10抗体(Invitrogen, RHCIL1001)被用于被用于免疫细胞化学在人类样本上浓度为1 ug/ml (图 3). Biosens Bioelectron (2011) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 猕猴
  • 流式细胞仪; African green monkey; 图 3
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于流式细胞仪在猕猴样本上 和 被用于流式细胞仪在African green monkey样本上 (图 3). Vet Immunol Immunopathol (2010) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol Methods (2008) ncbi
大鼠 单克隆(JES3-9D7)
  • 免疫组化; 猕猴
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于免疫组化在猕猴样本上. Cell Death Differ (2007) ncbi
小鼠 单克隆(945A5D11)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔IL-10抗体(BioSource, 945A5D11)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Inflamm Bowel Dis (2007) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
赛默飞世尔IL-10抗体(BioSource, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. Inflamm Bowel Dis (2007) ncbi
大鼠 单克隆(JES3-9D7)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于免疫组化-石蜡切片在人类样本上. J Immunol (2006) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类; 2.5 ul/10^6 cells
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ul/10^6 cells. Genes Immun (2006) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 人类; 1 ug/ml
赛默飞世尔IL-10抗体(Biosource, 945A 5D11)被用于被用于酶联免疫吸附测定在人类样本上浓度为1 ug/ml. Exp Gerontol (2006) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. Infect Immun (2005) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2005) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-10抗体(Biosource, . AHC7109)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). J Immunol Methods (2005) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 人类; 1 ug/ml; 表 1
赛默飞世尔IL-10抗体(Biosource, 945A5D11)被用于被用于酶联免疫吸附测定在人类样本上浓度为1 ug/ml (表 1). J Leukoc Biol (2004) ncbi
大鼠 单克隆(9D7)
  • 流式细胞仪; 猕猴
  • 免疫细胞化学; 猕猴
赛默飞世尔IL-10抗体(BioSource, 9D7)被用于被用于流式细胞仪在猕猴样本上 和 被用于免疫细胞化学在猕猴样本上. Viral Immunol (2003) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 5). J Rheumatol (2003) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类; 表 1
赛默飞世尔IL-10抗体(Endogen, 12G8)被用于被用于酶联免疫吸附测定在人类样本上 (表 1). Transplant Proc (2003) ncbi
大鼠 单克隆(9D7)
  • 酶联免疫吸附测定; 人类; 表 1
赛默飞世尔IL-10抗体(Endogen, 9D7)被用于被用于酶联免疫吸附测定在人类样本上 (表 1). Transplant Proc (2003) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 5 ug/ml; 图 1
赛默飞世尔IL-10抗体(BioSource, JES3-9D7)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml (图 1). J Immunol (2002) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Caltag, Jes3-9D7)被用于被用于流式细胞仪在人类样本上. J Exp Med (2002) ncbi
大鼠 单克隆(12G8)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-10抗体(Endogen, M011B)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Exp Lung Res (2002) ncbi
大鼠 单克隆(9D7)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-10抗体(Endogen, M010E)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Exp Lung Res (2002) ncbi
大鼠 单克隆(9D7)
  • 流式细胞仪; 猕猴
赛默飞世尔IL-10抗体(BioSource International, clone 9D7)被用于被用于流式细胞仪在猕猴样本上. J Infect Dis (2002) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2001) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2001) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 人类; 图 6
赛默飞世尔IL-10抗体(Biosource, clones 945A5D11)被用于被用于酶联免疫吸附测定在人类样本上 (图 6). J Immunol (2000) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; African green monkey; 3 ug/ml; 图 2
赛默飞世尔IL-10抗体(BioSource International, AHC8102)被用于被用于酶联免疫吸附测定在African green monkey样本上浓度为3 ug/ml (图 2). J Immunol (2000) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; African green monkey; 0.8 ug/ml; 图 2
赛默飞世尔IL-10抗体(BioSource International, AHC7109)被用于被用于酶联免疫吸附测定在African green monkey样本上浓度为0.8 ug/ml (图 2). J Immunol (2000) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-10抗体(BioSource, AHC8102)被用于被用于酶联免疫吸附测定在人类样本上. J Immunol (2000) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-10抗体(BioSource, AHC7109)被用于被用于酶联免疫吸附测定在人类样本上. J Immunol (2000) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; baboon ; 0.8 ug/ml
赛默飞世尔IL-10抗体(Biosource, AHC7109)被用于被用于酶联免疫吸附测定在baboon 样本上浓度为0.8 ug/ml. Infect Immun (1999) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; baboon ; 3 ug/ml
赛默飞世尔IL-10抗体(Biosource, AHC8102)被用于被用于酶联免疫吸附测定在baboon 样本上浓度为3 ug/ml. Infect Immun (1999) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; 猕猴; 图 5
赛默飞世尔IL-10抗体(Biosource, 945A5A10)被用于被用于酶联免疫吸附测定在猕猴样本上 (图 5). J Immunol (1999) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 猕猴; 图 5
赛默飞世尔IL-10抗体(Biosource, 945A5D11)被用于被用于酶联免疫吸附测定在猕猴样本上 (图 5). J Immunol (1999) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类; 图 4
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于酶联免疫吸附测定在人类样本上 (图 4). J Immunol (1999) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-10抗体(Caltag, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 2). Shock (1999) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
赛默飞世尔IL-10抗体(Caltag, JES3?C9D7)被用于被用于流式细胞仪在人类样本上. Mol Pharmacol (1999) ncbi
小鼠 单克隆(945A5A10)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-10抗体(Biosource, AHC7109)被用于被用于酶联免疫吸附测定在人类样本上. J Exp Med (1999) ncbi
小鼠 单克隆(945A5D11)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-10抗体(Biosource, AHC8102)被用于被用于酶联免疫吸附测定在人类样本上. J Exp Med (1999) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. Immunology (1998) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
赛默飞世尔IL-10抗体(Biosource, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (1997) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-10抗体(noco, noca)被用于被用于酶联免疫吸附测定在人类样本上. Science (1991) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-10抗体(noco, JES3-12G8)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Cytokine (1992) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-10抗体(noco, noca)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). J Immunol (1992) ncbi
BioLegend
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Arthritis Res Ther (2021) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 1b
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2019) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 1e
BioLegendIL-10抗体(BioLegend, 501426)被用于被用于流式细胞仪在人类样本上 (图 1e). Cell (2019) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 s6c
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 s6c). Leukemia (2019) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 4a
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Exp Med (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类; 100 ug/ml; 图 7a
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于抑制或激活实验在人类样本上浓度为100 ug/ml (图 7a). Am J Trop Med Hyg (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 4c
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 4c). Front Immunol (2017) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2a
BioLegendIL-10抗体(Biolegend, 501420)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell Death Dis (2017) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 3d
BioLegendIL-10抗体(Biolegend, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 3d). Ann Rheum Dis (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • mass cytometry; 人类; 图 2a
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 表 s9
BioLegendIL-10抗体(BioLegend, 501404)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2c
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 2c). Cell Death Dis (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; black flying fox; 图 6b
BioLegendIL-10抗体(Biolegend, JES3-19F1)被用于被用于流式细胞仪在black flying fox样本上 (图 6b). Sci Rep (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 s2b
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 s2b). J Immunol (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 5d
BioLegendIL-10抗体(Biolegend, 501410)被用于被用于流式细胞仪在人类样本上 (图 5d). Cell (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS Pathog (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 s5h
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 s5h). Eur J Immunol (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 2a
BioLegendIL-10抗体(Biolegend, JE53-9D7)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS Pathog (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 8b
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 8b). J Biol Chem (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类; 1 ug/ml
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Sci Transl Med (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类; 图 4
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于抑制或激活实验在人类样本上 (图 4). PLoS Pathog (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
BioLegendIL-10抗体(Biolegend, 50141)被用于被用于流式细胞仪在人类样本上. Scand J Med Sci Sports (2016) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
BioLegendIL-10抗体(Biolegend, clone JES3-9D7)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类
BioLegendIL-10抗体(Biolegend, 506804)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 5 ul/test
BioLegendIL-10抗体(Biolegend, JES3-9D7)被用于被用于流式细胞仪在人类样本上浓度为5 ul/test. J Immunol Methods (2015) ncbi
大鼠 单克隆(JES3-12G8)
  • dot blot; 人类; 表 s1
BioLegendIL-10抗体(Biolegend, 501504)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • dot blot; 人类; 表 s1
BioLegendIL-10抗体(Biolegend, 501402)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 抑制或激活实验; 人类
BioLegendIL-10抗体(BioLegend, JES3-9D7)被用于被用于抑制或激活实验在人类样本上. J Immunol (2015) ncbi
大鼠 单克隆(JES3-19F1)
BioLegendIL-10抗体(Biolegend, JES3-19F1)被用于. PLoS ONE (2014) ncbi
大鼠 单克隆(JES3-19F1)
BioLegendIL-10抗体(Biolegend, JES3-19F1)被用于. J Immunol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(E-10)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术IL-10抗体(Santa Cruz, sc-8438)被用于被用于免疫印迹在人类样本上 (图 3). BMC Med Genomics (2015) ncbi
小鼠 单克隆(E-10)
  • 免疫细胞化学; 人类; 图 3d
  • 免疫印迹; 人类; 1:500; 图 3n
圣克鲁斯生物技术IL-10抗体(Santa Cruz Biotechnology, sc-8438)被用于被用于免疫细胞化学在人类样本上 (图 3d) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 3n). Eur J Immunol (2016) ncbi
小鼠 单克隆(E-10)
  • 免疫组化; 人类; 图 2d
圣克鲁斯生物技术IL-10抗体(Santa Cruz Biotechnology, sc-8438)被用于被用于免疫组化在人类样本上 (图 2d). elife (2015) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(4A7-25-17)
  • 免疫印迹; 小鼠; 1:500; 图 4
艾博抗(上海)贸易有限公司IL-10抗体(Abcam, ab134742)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4). Int J Mol Med (2016) ncbi
亚诺法生技股份有限公司
小鼠 单克隆(1C10)
  • 免疫印迹; 人类
亚诺法生技股份有限公司IL-10抗体(Abnova, 1C10)被用于被用于免疫印迹在人类样本上. Clin Exp Immunol (2014) ncbi
碧迪BD
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 8d
碧迪BDIL-10抗体(BD Biosciences, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 8d). J Clin Invest (2022) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 表 1
碧迪BDIL-10抗体(BD Biosciences, 554498)被用于被用于流式细胞仪在人类样本上 (表 1). J Clin Invest (2018) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 s6
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 s6). Eur J Immunol (2018) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; African green monkey; 图 s4b
碧迪BDIL-10抗体(BD Biosciences, JES3-9D7)被用于被用于流式细胞仪在African green monkey样本上 (图 s4b). Nature (2017) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 图 3a
碧迪BDIL-10抗体(BD Biosciences, JES3-9D7)被用于被用于流式细胞仪在人类样本上 (图 3a). Int J Cancer (2017) ncbi
大鼠 单克隆(JES3-19F1)
  • 酶联免疫吸附测定; 人类; 图 1
碧迪BDIL-10抗体(BD Biosciences, JES3-19 F1)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Arthritis Res Ther (2016) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类; 图 1
碧迪BDIL-10抗体(BD Biosciences, JES3-12G8)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Arthritis Res Ther (2016) ncbi
大鼠 单克隆(JES3-12G8)
  • 免疫组化-冰冻切片; 人类
碧迪BDIL-10抗体(BD Biosciences Pharmingen, JES3-12G8)被用于被用于免疫组化-冰冻切片在人类样本上. Tech Coloproctol (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 6
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 6). J Transl Med (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 酶联免疫吸附测定; 人类; 图 4a
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于酶联免疫吸附测定在人类样本上 (图 4a). J Immunol (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 4e
碧迪BDIL-10抗体(BD Biosciences, JES3-19 F1)被用于被用于流式细胞仪在人类样本上 (图 4e). Arthritis Res Ther (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 3d
碧迪BDIL-10抗体(BD Pharmingen, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 3d). PLoS ONE (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 s1
碧迪BDIL-10抗体(BD Biosciences, JEF3-19F1)被用于被用于流式细胞仪在人类样本上 (图 s1). Sci Transl Med (2015) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 4c
碧迪BDIL-10抗体(BD-PharMingen, 554707)被用于被用于流式细胞仪在人类样本上 (图 4c). Hum Vaccin Immunother (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 4
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 4). Mucosal Immunol (2016) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 6:100; 图 3a
碧迪BDIL-10抗体(Becton Dickinson, JES3-19F1)被用于被用于流式细胞仪在人类样本上浓度为6:100 (图 3a). Nat Commun (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类; 5 ug/ml; 图 3
碧迪BDIL-10抗体(BD Biosciences, JES3-9D7)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml (图 3). J Autoimmun (2015) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类; 图 1
碧迪BDIL-10抗体(BD Pharmingen, JES3-19F1)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
大鼠 单克隆(JES3-19F1)
  • 抑制或激活实验; 人类; 图 5b
碧迪BDIL-10抗体(BD Bioscience, 554703)被用于被用于抑制或激活实验在人类样本上 (图 5b). Immunol Res (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
碧迪BDIL-10抗体(BD Pharmingen, clone JES3-9D7)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类
碧迪BDIL-10抗体(BD, JES3-19F1)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2015) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类; 1:1000
碧迪BDIL-10抗体(BD Pharmingen, JES3-12G8)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:1000. Nat Commun (2014) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类; 1:1000
碧迪BDIL-10抗体(BD Pharmingen, JES3-9D7)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:1000. Nat Commun (2014) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 人类
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(JES3-19F1)
  • 流式细胞仪; 大鼠; 图 6
碧迪BDIL-10抗体(BD Biosciences, JES3-19F1)被用于被用于流式细胞仪在大鼠样本上 (图 6). Eur J Immunol (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 流式细胞仪; 人类
碧迪BDIL-10抗体(BD Bioscience, JES3-9D7)被用于被用于流式细胞仪在人类样本上. Immunology (2015) ncbi
大鼠 单克隆(JES3-9D7)
  • 酶联免疫吸附测定; 人类
碧迪BDIL-10抗体(PharMingen, JES3-9D)被用于被用于酶联免疫吸附测定在人类样本上. J Biol Chem (2002) ncbi
大鼠 单克隆(JES3-12G8)
  • 酶联免疫吸附测定; 人类
碧迪BDIL-10抗体(PharMingen, JES3-12G8)被用于被用于酶联免疫吸附测定在人类样本上. J Biol Chem (2002) ncbi
文章列表
  1. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed 出版商
  2. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed 出版商
  3. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed 出版商
  4. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed 出版商
  5. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  6. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed 出版商
  7. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed 出版商
  8. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed 出版商
  9. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  10. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed 出版商
  11. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed 出版商
  12. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed 出版商
  13. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed 出版商
  14. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed 出版商
  15. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed 出版商
  16. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed 出版商
  17. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  18. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed 出版商
  19. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  20. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed 出版商
  21. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  22. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed 出版商
  23. Martínez Gómez J, Periasamy P, Dutertre C, Irving A, Ng J, Crameri G, et al. Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto. Sci Rep. 2016;6:37796 pubmed 出版商
  24. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  25. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  26. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  27. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed 出版商
  28. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
  29. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  30. Dahal L, Basu N, Youssef H, Khanolkar R, Barker R, Erwig L, et al. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:180 pubmed 出版商
  31. Hou C, Wu Q, Ouyang C, Huang T. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 2016;38:713-20 pubmed 出版商
  32. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  33. van Onkelen R, Gosselink M, Van Meurs M, Melief M, Schouten W, Laman J. Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 2016;20:619-25 pubmed 出版商
  34. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  35. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed 出版商
  36. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed 出版商
  37. Roth S, Spalinger M, Gottier C, Biedermann L, Zeitz J, Lang S, et al. Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis. PLoS ONE. 2016;11:e0154817 pubmed 出版商
  38. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  39. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed 出版商
  40. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  41. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed 出版商
  42. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  43. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed 出版商
  44. Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma. BMC Med Genomics. 2015;8:81 pubmed 出版商
  45. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed 出版商
  46. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  47. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  48. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed 出版商
  49. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed 出版商
  50. Gulati N, Suárez Fariñas M, Correa Da Rosa J, Krueger J. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149 pubmed 出版商
  51. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  52. Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog. 2015;11:e1004906 pubmed 出版商
  53. van de Vyver M, Engelbrecht L, Smith C, Myburgh K. Neutrophil and monocyte responses to downhill running: Intracellular contents of MPO, IL-6, IL-10, pstat3, and SOCS3. Scand J Med Sci Sports. 2016;26:638-47 pubmed 出版商
  54. Prata T, Bonin C, Ferreira A, Padovani C, Fernandes C, Machado A, et al. Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology. 2015;146:113-21 pubmed 出版商
  55. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  56. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  57. Riccio E, Pratt Riccio L, Bianco Júnior C, Sanchez V, Totino P, Carvalho L, et al. Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research. Malar J. 2015;14:166 pubmed 出版商
  58. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  59. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed 出版商
  60. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  61. Nouël A, Pochard P, Simon Q, Ségalen I, Le Meur Y, Pers J, et al. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner. J Autoimmun. 2015;59:53-60 pubmed 出版商
  62. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed 出版商
  63. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed 出版商
  64. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed 出版商
  65. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed 出版商
  66. Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, et al. CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway. J Immunol. 2015;194:960-72 pubmed 出版商
  67. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed 出版商
  68. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed 出版商
  69. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  70. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  71. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed 出版商
  72. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  73. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed 出版商
  74. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed 出版商
  75. Preciado Llanes L, Wing J, Foster R, Carlring J, Lees A, Read R, et al. Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking. Immunology. 2014;: pubmed 出版商
  76. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed 出版商
  77. Kyriakidis N, Kapsogeorgou E, Gourzi V, Konsta O, Baltatzis G, Tzioufas A. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin Exp Immunol. 2014;178:548-60 pubmed 出版商
  78. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed 出版商
  79. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed 出版商
  80. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed 出版商
  81. Auerbach P, Nordby P, Bendtsen L, Mehlsen J, Basnet S, Vestergaard H, et al. Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men. Am J Physiol Regul Integr Comp Physiol. 2013;305:R490-8 pubmed 出版商
  82. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed 出版商
  83. Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS ONE. 2012;7:e44915 pubmed 出版商
  84. Konry T, Dominguez Villar M, Baecher Allan C, Hafler D, Yarmush M. Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine. Biosens Bioelectron. 2011;26:2707-10 pubmed 出版商
  85. de Campos S, Souza Lemos C, Teva A, Porrozzi R, Grimaldi G. Systemic and compartmentalised immune responses in a Leishmania braziliensis-macaque model of self-healing cutaneous leishmaniasis. Vet Immunol Immunopathol. 2010;137:149-54 pubmed 出版商
  86. Della Bella S, Giannelli S, Taddeo A, Presicce P, Villa M. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods. 2008;339:153-64 pubmed 出版商
  87. Cumont M, Monceaux V, Viollet L, Lay S, Parker R, Hurtrel B, et al. TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ. 2007;14:1747-58 pubmed 出版商
  88. Freysdottir J, Zhang S, Tilakaratne W, Fortune F. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis. 2007;13:439-45 pubmed
  89. Yu Q, Saruta M, Avanesyan A, Fleshner P, Banham A, Papadakis K. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007;13:191-9 pubmed
  90. Uhlig H, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol. 2006;177:5852-60 pubmed
  91. Ohman H, Tiitinen A, Halttunen M, Birkelund S, Christiansen G, Koskela P, et al. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun. 2006;7:243-9 pubmed
  92. Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006;41:312-9 pubmed
  93. Kariminia A, Bourreau E, Pascalis H, Couppie P, Sainte Marie D, Tacchini Cottier F, et al. Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun. 2005;73:5908-14 pubmed
  94. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175:1145-52 pubmed
  95. Thom F, Stockhausen H, Germann T, Frosch S, Wade E. Biological inactivation and impaired detection of IL-10 by suramin. J Immunol Methods. 2005;299:91-8 pubmed
  96. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed
  97. Hoffman S, Polack F, Hauer D, Griffin D. Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol. 2003;16:369-79 pubmed
  98. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  99. Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C, et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 2003;35:1523-6 pubmed
  100. Cousins D, Lee T, Staynov D. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol. 2002;169:2498-506 pubmed
  101. Reignat S, Webster G, Brown D, Ogg G, King A, Seneviratne S, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med. 2002;195:1089-101 pubmed
  102. Leboulle G, Crippa M, Decrem Y, Mejri N, Brossard M, Bollen A, et al. Characterization of a novel salivary immunosuppressive protein from Ixodes ricinus ticks. J Biol Chem. 2002;277:10083-9 pubmed
  103. Suwa T, Hogg J, Vincent R, Mukae H, Fujii T, van Eeden S. Ambient air particulates stimulate alveolar macrophages of smokers to promote differentiation of myeloid precursor cells. Exp Lung Res. 2002;28:1-18 pubmed
  104. Polack F, Hoffman S, Moss W, Griffin D. Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis. 2002;185:13-9 pubmed
  105. Van Damme N, De Keyser F, Demetter P, Baeten D, Mielants H, Verbruggen G, et al. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol. 2001;125:383-90 pubmed
  106. Van Damme N, De Vos M, Baeten D, Demetter P, Mielants H, Verbruggen G, et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis. 2001;60:495-9 pubmed
  107. Thoma Uszynski S, Kiertscher S, Ochoa M, Bouis D, Norgard M, Miyake K, et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol. 2000;165:3804-10 pubmed
  108. Farah I, Mola P, Kariuki T, Nyindo M, Blanton R, King C. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. J Immunol. 2000;164:5337-43 pubmed
  109. Braun M, Lahey E, Kelsall B. Selective suppression of IL-12 production by chemoattractants. J Immunol. 2000;164:3009-17 pubmed
  110. Mola P, Farah I, Kariuki T, Nyindo M, Blanton R, King C. Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment. Infect Immun. 1999;67:6565-71 pubmed
  111. Kenney R, Sacks D, Sypek J, Vilela L, Gam A, Evans Davis K. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol. 1999;163:4481-8 pubmed
  112. Prehn J, Landers C, Targan S. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells. J Immunol. 1999;163:4277-83 pubmed
  113. Shimonkevitz R, Bar Or D, Harris L, Dole K, McLaughlin L, Yukl R. Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock. 1999;12:10-6 pubmed
  114. Koshiba M, Rosin D, Hayashi N, Linden J, Sitkovsky M. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol. 1999;55:614-24 pubmed
  115. Braun M, He J, Wu C, Kelsall B. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med. 1999;189:541-52 pubmed
  116. Kanto T, Hayashi N, Takehara T, Katayama K, Ito A, Mochizuki K, et al. Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro. Immunology. 1998;94:461-8 pubmed
  117. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte H. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol. 1997;27:2994-3000 pubmed
  118. Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991;254:279-82 pubmed
  119. Gotlieb W, Abrams J, Watson J, Velu T, Berek J, Martínez Maza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine. 1992;4:385-90 pubmed
  120. Yssel H, de Waal Malefyt R, Roncarolo M, Abrams J, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 1992;149:2378-84 pubmed